Core Viewpoint - Analysts project that Expedia (EXPE) will report quarterly earnings of $0.42 per share, reflecting a 100% year-over-year increase, with revenues expected to reach $3.03 billion, a 4.8% increase from the same quarter last year [1]. Earnings Estimates - The consensus EPS estimate has been revised 4.9% lower over the last 30 days, indicating a reevaluation of initial estimates by analysts [2]. - Prior to earnings releases, revisions to earnings projections are crucial for predicting investor behavior, as empirical studies show a strong correlation between earnings estimate trends and short-term stock performance [3]. Revenue Projections - Analysts predict 'Revenue- B2B' will reach $924.59 million, marking an 11% increase year-over-year [5]. - 'Revenue by Service Type- Lodging' is expected to be $2.36 billion, reflecting a 6.1% year-over-year change [5]. - 'Revenue- Trivago' is projected at $74.76 million, indicating a 6.8% increase from the prior year [5]. - 'Revenue by Service Type- Air' is estimated at $114.41 million, suggesting a slight decline of 0.5% year-over-year [6]. - 'Revenue- Advertising, Media and other' is expected to reach $277.37 million, a 12.3% increase from the previous year [6]. - 'Revenue- International' is projected at $1.22 billion, reflecting an 11.3% increase year-over-year [7]. - 'Revenue- United States' is estimated at $1.85 billion, indicating a 3.3% year-over-year change [7]. Gross Bookings - Analysts forecast 'Gross bookings - Total' to reach $31.85 billion, compared to $30.16 billion from the previous year [7]. - 'Gross bookings - Merchant' is expected to be $18.83 billion, up from $16.86 billion year-over-year [8]. - 'Gross bookings - Agency' is projected at $13.81 billion, compared to $13.30 billion from the prior year [9]. Key Metrics - The consensus estimate for 'Stayed room nights/ Booked room nights' stands at 106, up from 101 year-over-year [8]. - 'Stayed Room Night /Booked room nights Growth' is expected to be 8.1%, compared to 7% in the same quarter last year [8]. Stock Performance - Over the past month, shares of Expedia have returned +14.1%, significantly outperforming the Zacks S&P 500 composite's +0.4% [9].

The upcoming report from Dutch Bros (BROS) is expected to reveal quarterly earnings of $0.10 per share, indicating an increase of 11.1% compared to the year-ago period. Analysts forecast revenues of $343.5 million, representing an increase of 24.9% year over year.The current level reflects a downward revision of 1.5% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projections over this peri ...

Core Insights - Jackson Financial (JXN) is expected to report quarterly earnings of $4.93 per share, reflecting a 16.6% increase year over year, while revenues are forecasted to decline by 35.9% to $1.78 billion [1] Earnings Projections - There has been a downward revision of 10.2% in the consensus EPS estimate over the last 30 days, indicating analysts' reassessment of their initial forecasts [2] - Changes in earnings projections are crucial for predicting investor reactions, with empirical studies showing a strong correlation between earnings estimate trends and short-term stock price movements [3] Revenue Estimates - Analysts estimate 'Revenues- Net investment income' at $490.40 million, a decrease of 33.2% year over year [5] - The 'Revenues- Premium' is projected at $35.41 million, indicating a year-over-year decline of 6.8% [5] - 'Revenues- Fee income' is expected to be $1.24 billion, reflecting a 38.2% decrease from the prior-year quarter [5] Adjusted Earnings Before Tax - The consensus estimate for 'Adjusted earnings before tax- Retail Annuities' is $471.09 million, up from $419 million year over year [6] - 'Adjusted earnings before tax- Closed Life and Annuity Blocks' is projected at $7.24 million, down from $19 million in the previous year [6] - Analysts expect 'Adjusted earnings before tax- Institutional Products' to reach $21.98 million, compared to $31 million in the same quarter last year [7] Stock Performance - Jackson Financial shares have returned +16% over the past month, outperforming the Zacks S&P 500 composite, which saw a +0.4% change [7] - The company holds a Zacks Rank 4 (Sell), suggesting it may underperform the overall market in the near future [7]

Group 1 - The AZEK Company is expected to report quarterly earnings of $0.44 per share, reflecting a 12.8% increase year over year [1] - Analysts forecast revenues of $443.6 million, indicating a 6% year-over-year growth [1] - There has been no revision in the consensus EPS estimate for the quarter over the past 30 days, suggesting stability in analysts' projections [1] Group 2 - Analysts project 'Net Sales- Commercial' to reach $15.07 million, a decrease of 5% from the prior-year quarter [4] - The estimated 'Net Sales- Residential' is $431.37 million, representing a 7.2% increase year over year [4] - The average prediction for 'Adjusted EBITDA- Residential' is $119.21 million, up from $110.39 million in the previous year [4] Group 3 - Shares of The AZEK Company have increased by 8.1% in the past month, outperforming the Zacks S&P 500 composite, which moved up by 0.4% [5] - The company holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the overall market in the near future [5]

Analysts on Wall Street project that Warner Bros. Discovery (WBD) will announce quarterly loss of $0.14 per share in its forthcoming report, representing an increase of 65% year over year. Revenues are projected to reach $9.75 billion, declining 2.1% from the same quarter last year.The current level reflects an upward revision of 2.3% in the consensus EPS estimate for the quarter over the past 30 days. This demonstrates how the analysts covering the stock have collectively reappraised their initial projecti ...

Core Viewpoint - Analysts project that Molson Coors Brewing (TAP) will report quarterly earnings of $0.80 per share, reflecting a 15.8% decline year over year, with revenues expected to reach $2.44 billion, down 6% from the same quarter last year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 0.3% over the past 30 days, indicating a collective reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Key Metrics Forecast - Analysts estimate 'Net Sales- EMEA&APAC' at $451.89 million, a decrease of 0.6% from the prior-year quarter [5]. - 'Net Sales- Americas' is projected at $1.96 billion, reflecting an 8.7% decline from the same quarter last year [5]. - 'Brand Volume - Consolidated' is expected to reach 16.52 million, down from 16.9 million year-over-year [5]. Brand Volumes - 'Brand Volumes - Americas' is estimated at 12.42 million, compared to 12.89 million in the same quarter last year [6]. - 'Brand Volumes - EMEA&APAC' is projected at 3.82 million, down from 4.01 million in the same quarter last year [6]. Operating Income - The consensus for 'Operating income(loss)- Americas' is $271.60 million, a decrease from $320.60 million reported in the same quarter last year [7]. - Molson Coors shares have declined by 5.9% in the past month, contrasting with a 0.4% increase in the Zacks S&P 500 composite [7].

Core Viewpoint - Nutrien (NTR) is expected to report a quarterly earnings per share (EPS) of $0.33, reflecting a 28.3% decline year-over-year, with revenues forecasted at $5.32 billion, a decrease of 1.2% from the previous year [1]. Earnings Estimates - The consensus EPS estimate has been revised 0.5% higher in the last 30 days, indicating a collective reevaluation by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior and stock performance [3]. Sales and Revenue Projections - Analysts predict 'Sales- Retail Total' to reach $3.49 billion, marking a 5.6% increase from the year-ago quarter [4]. - 'Sales- Nitrogen' is expected to be $972.08 million, down 5.4% year-over-year [5]. - 'Sales- Potash' is forecasted at $783.90 million, indicating a 15.4% decline from the prior year [5]. - 'Sales- Phosphate' is estimated at $435.19 million, reflecting a 12.8% decrease from the previous year [5]. Volume and Pricing Estimates - 'Tonnes Sold - Potash - Total' is projected at 3,255.30 KTon, down from 3,413 KTon year-over-year [6]. - 'Tonnes Sold - Nitrogen' is expected to be 2,473.23 KTon, slightly down from 2,507 KTon [6]. - The average selling price for 'Phosphate - Industrial and feed' is estimated at $777.80 per tonne, down from $848 per tonne in the same quarter last year [7]. - The average selling price for 'Phosphate - Total' is projected at $614.19 per tonne, compared to $689 per tonne a year ago [7]. - 'Average Selling Price per Tonne - Nitrogen - Solutions, nitrates and sulphates' is expected to be $220.56 per tonne, down from $226 per tonne [8]. - 'Average Selling Price per Tonne - Nitrogen - Urea and ESN' is estimated at $410.89 per tonne, compared to $432 per tonne last year [8]. - 'Average Selling Price per Tonne - Nitrogen - Ammonia' is forecasted at $417.19 per tonne, slightly up from $403 per tonne [9]. - 'Tonnes Sold - Phosphate' is expected to be 569.00 KTon, down from 620 KTon in the same quarter last year [9]. Stock Performance - Over the past month, Nutrien shares have returned +11.9%, while the Zacks S&P 500 composite has seen a -0.5% change [9]. - Nutrien currently holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [10].

Core Viewpoint - AMC Entertainment is expected to report a quarterly loss of $0.56 per share, reflecting a year-over-year increase of 28.2%, with revenues projected at $874.53 million, down 8.1% from the previous year [1]. Group 1: Earnings Projections - Over the last 30 days, the consensus EPS estimate for AMC has been revised upward by 15.7%, indicating a collective reassessment by analysts [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Group 2: Revenue Estimates - Analysts estimate 'Revenues- Food and beverage' to reach $294.23 million, representing a decline of 8.4% year-over-year [5]. - The 'Revenues- Other theatre' is projected at $91.87 million, indicating a year-over-year decrease of 7.9% [5]. - 'Revenues- Admissions' are expected to be $488.40 million, also suggesting a year-over-year change of -7.9% [5]. Group 3: Stock Performance - AMC Entertainment shares have increased by 0.4% over the past month, contrasting with a -0.5% change in the Zacks S&P 500 composite [6]. - With a Zacks Rank of 3 (Hold), AMC is anticipated to closely follow overall market performance in the near term [6].

Core Viewpoint - Cencora (COR) is expected to report quarterly earnings of $4.08 per share, reflecting a 7.4% increase year-over-year, with revenues projected at $74.82 billion, indicating a 9.4% growth compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised upward by 0.2% in the last 30 days, showcasing analysts' reassessment of their initial projections [2]. - Changes in earnings projections are crucial for predicting investor reactions, as empirical studies show a strong correlation between earnings estimate trends and short-term stock price movements [3]. Revenue Estimates - Analysts estimate 'Revenue- Total International Healthcare Solutions' at $7.36 billion, a year-over-year increase of 3.3% [5]. - The consensus for 'Revenue- Total U.S. Healthcare Solutions' is $67.56 billion, reflecting a 10.2% increase from the same quarter last year [5]. - 'Revenue- International Healthcare Solutions- Alliance Healthcare' is projected to reach $5.98 billion, indicating a 3.9% year-over-year change [6]. - 'Revenue- U.S. Healthcare Solutions- Animal Health' is expected to be $1.49 billion, suggesting a 14.1% increase year-over-year [6]. - 'Revenue- U.S. Healthcare Solutions- Human Health' is forecasted at $65.56 billion, reflecting a 9.3% year-over-year growth [6]. - 'Revenue- International Healthcare Solutions- Other Healthcare Solutions' is estimated at $1.42 billion, indicating a 3.8% increase from the previous year [7]. Operating Income Estimates - Analysts project 'Operating income- Non-GAAP- International Healthcare Solutions' to be $182.43 million, down from $192.72 million reported in the same quarter last year [7]. - 'Operating income- Non-GAAP- U.S. Healthcare Solutions' is expected to reach $926.36 million, compared to $841.06 million from the previous year [8]. Stock Performance - Over the past month, Cencora shares have returned +0.4%, outperforming the Zacks S&P 500 composite, which recorded a -0.5% change [8].

Core Viewpoint - Estee Lauder is expected to report a significant decline in quarterly earnings and revenues, reflecting a downward revision in analysts' projections over the past month [1][2]. Financial Performance - The anticipated earnings per share (EPS) for Estee Lauder is $0.29, representing a 70.1% decline year over year [1]. - Analysts forecast revenues of $3.51 billion, indicating an 11% decrease compared to the previous year [1]. - The consensus EPS estimate has been revised down by 8.5% over the last 30 days [1]. Sales Projections by Category - Net sales for Skin Care are projected to reach $1.87 billion, down 9.3% year over year [4]. - Makeup net sales are expected to be $1.07 billion, reflecting a 6% decrease from the prior year [4]. - Other net sales are estimated at -$38.46 million, indicating a drastic decline of 247.9% year over year [4]. - Hair Care net sales are forecasted at $134.79 million, down 5.7% from the previous year [5]. - Fragrance net sales are projected to be $574.19 million, showing a slight decrease of 0.1% [5]. - Net sales in The Americas are expected to reach $1.08 billion, down 3.1% year over year [5]. - Sales in Europe, the Middle East & Africa are estimated at $1.40 billion, reflecting a 15.1% decline [6]. - Asia/Pacific net sales are projected at $1.02 billion, indicating a 13.3% decrease [6]. Operating Income Projections - Operating income for Skin Care is expected to be $354.08 million, down from $468 million year over year [6]. - Operating income for Other is projected at -$220.82 million, compared to a positive $11 million last year [7]. - Makeup operating income is estimated at $53.44 million, down from $66 million [7]. - Fragrance operating income is expected to be $17.18 million, compared to $29 million in the previous year [8]. Stock Performance - Estee Lauder shares have decreased by 12.2% over the past month, contrasting with the Zacks S&P 500 composite's decline of only 0.2% [8].